Search - tctmd.com

Displaying 361 - 380 of 1067

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

Taking Ticagrelor? Frank, Proactive Patient Conversations are Needed to Help With Adherence

News Daily News

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Yael L. Maxwell

May 17, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Caitlin E. Cox

May 10, 2019

Presentation ARCH 2019

Update on Left Main and Bifurcation Treatment

Presenter: Yves Louvard

April 12, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

Shelley Wood

March 29, 2019

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Conference News ACC 2019

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Yael L. Maxwell

March 18, 2019

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Caitlin E. Cox

March 17, 2019

Presentation CTO 2019

Donor Vessel Dissection/Thrombosis and Management

Presenter: Darshan Doshi

March 01, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

Presentation

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

January 15, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

Todd Neale

January 14, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Caitlin E. Cox

December 11, 2018

News Daily News

US and European DAPT Guidelines More Alike Than Different, Say Experts

Yael L. Maxwell

December 03, 2018

News Daily News

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

Caitlin E. Cox

November 28, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

Advertisement

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Update on Left Main and Bifurcation Treatment

TCTMD’s Top 10 Most Popular Stories for March 2019

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Donor Vessel Dissection/Thrombosis and Management

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

Top News in Coronary Artery Disease: 2018

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

US and European DAPT Guidelines More Alike Than Different, Say Experts

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content